retatrutide ly3437943 phase 2 trial obesity nejm 2023 Another Promising Medication (Retatrutide) for Retatrutide: Phase 3 Results, Uses

The total synthesis of glucagon had been achieved in 1968 by a large research group headed by Erich Wnsch in Munich, Germany [26], using painstaking solution methodology to create and then stitch together smaller fragments to obtain the full molecule

While there are a few annoyances, they haven't been dealbreakers

Although data from early phase trials suggest that retatrutide is well tolerated with a similar adverse event profile to GLP-1 RAs, additional research assessing long-term safety and efficacy of retatrutide in people living with obesity and/or T2D (including cardiovascular outcomes) is awaited over the next five years

Hydration, movement, and dietary adjustments often help, but ongoing symptoms should be addressed